175 related articles for article (PubMed ID: 24827571)
1. Comparative pharmacodynamics of pancuronium, cisatracurium, and CW002 in rabbits.
Diaz LL; Zhang J; Heerdt PM
J Am Assoc Lab Anim Sci; 2014 May; 53(3):283-9. PubMed ID: 24827571
[TBL] [Abstract][Full Text] [Related]
2. Cysteine reversal of the novel neuromuscular blocking drug CW002 in dogs: pharmacodynamics, acute cardiovascular effects, and preliminary toxicology.
Sunaga H; Malhotra JK; Yoon E; Savarese JJ; Heerdt PM
Anesthesiology; 2010 Apr; 112(4):900-9. PubMed ID: 20234310
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics and cardiopulmonary side effects of CW002, a cysteine-reversible neuromuscular blocking drug in dogs.
Heerdt PM; Malhotra JK; Pan BY; Sunaga H; Savarese JJ
Anesthesiology; 2010 Apr; 112(4):910-6. PubMed ID: 20234311
[TBL] [Abstract][Full Text] [Related]
4. Dose-response relation for atracurium, ORG NC 45 and pancuronium.
Gramstad L; Lilleaasen P
Br J Anaesth; 1982 Jun; 54(6):647-51. PubMed ID: 6123339
[TBL] [Abstract][Full Text] [Related]
5. [The clinical pharmacology of new benzylisoquinoline-diester compounds, with special consideration of cisatracurium and mivacurium].
Savarese JJ; Lien CA; Belmont MR; Wastila WB
Anaesthesist; 1997 Oct; 46(10):840-9. PubMed ID: 9424966
[TBL] [Abstract][Full Text] [Related]
6. [Effects of priming technique on onset profile of cisatracurium].
Hoffmann W; Schwarz U; Ruoff M; Georgieff M; Geldner G
Anaesthesiol Reanim; 1999; 24(5):130-3. PubMed ID: 10596204
[TBL] [Abstract][Full Text] [Related]
7. Effects of cisatracurium in children during halothane-nitrous oxide anesthesia.
Brandom BW; Woelfel SK; Ference A; Dayal B; Cook DR; Kerls S
J Clin Anesth; 1998 May; 10(3):195-9. PubMed ID: 9603588
[TBL] [Abstract][Full Text] [Related]
8. Gantacurium and CW002 do not potentiate muscarinic receptor-mediated airway smooth muscle constriction in guinea pigs.
Sunaga H; Zhang Y; Savarese JJ; Emala CW
Anesthesiology; 2010 Apr; 112(4):892-9. PubMed ID: 20216393
[TBL] [Abstract][Full Text] [Related]
9. [The clinical pharmacology of cisatracurium].
Mellinghoff H; Diefenbach C
Anaesthesist; 1997 Jun; 46(6):481-5. PubMed ID: 9297378
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic/Pharmacodynamic Model of CW002, an Investigational Intermediate Neuromuscular Blocking Agent, in Healthy Volunteers.
Kaullen JD; Owen JS; Brouwer KLR; Heerdt PM; Lien CA; Savarese JJ; Schmith VD
Anesthesiology; 2018 Jun; 128(6):1107-1116. PubMed ID: 29494403
[TBL] [Abstract][Full Text] [Related]
11. Cisatracurium during halothane and balanced anaesthesia in children.
Meretoja OA; Taivainen T; Wirtavuori K
Paediatr Anaesth; 1996; 6(5):373-8. PubMed ID: 8880817
[TBL] [Abstract][Full Text] [Related]
12. Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice.
Bryson HM; Faulds D
Drugs; 1997 May; 53(5):848-66. PubMed ID: 9129870
[TBL] [Abstract][Full Text] [Related]
13. Recovery from neuromuscular blockade after either bolus and prolonged infusions of cisatracurium or rocuronium using either isoflurane or propofol-based anesthetics.
Jellish WS; Brody M; Sawicki K; Slogoff S
Anesth Analg; 2000 Nov; 91(5):1250-5. PubMed ID: 11049917
[TBL] [Abstract][Full Text] [Related]
14. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion.
Mellinghoff H; Radbruch L; Diefenbach C; Buzello W
Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288
[TBL] [Abstract][Full Text] [Related]
15. Dose-response and Cardiopulmonary Side Effects of the Novel Neuromuscular-blocking Drug CW002 in Man.
Heerdt PM; Sunaga H; Owen JS; Murrell MT; Malhotra JK; Godfrey D; Steinkamp M; Savard P; Savarese JJ; Lien CA
Anesthesiology; 2016 Dec; 125(6):1136-1143. PubMed ID: 27749289
[TBL] [Abstract][Full Text] [Related]
16. Duration and recovery profile of cisatracurium after succinylcholine during propofol or isoflurane anesthesia.
Soppitt AJ; Glass PS; el-Moalem H; Ginsberg B; Weatherwax K; Gan TJ
J Clin Anesth; 1999 Dec; 11(8):652-6. PubMed ID: 10680107
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the neuromuscular blocking effects of cisatracurium during isoflurane or propofol anesthesia in dogs.
Chen IY; Liang YY; Chen KS; Lee WM; Wang HC
Vet Anaesth Analg; 2020 Jul; 47(4):454-462. PubMed ID: 32409258
[TBL] [Abstract][Full Text] [Related]
18. Tachyphylaxis associated with continuous cisatracurium versus pancuronium therapy.
Kanji S; Barletta JF; Janisse JJ; Kruse JA; Devlin JW
Pharmacotherapy; 2002 Jul; 22(7):823-30. PubMed ID: 12126215
[TBL] [Abstract][Full Text] [Related]
19. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
Stevens JB; Walker SC; Fontenot JP
Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the variability of the onset and recovery from neuromuscular blockade with cisatracurium versus rocuronium in elderly patients under total intravenous anesthesia.
Xiaobo F; Jianjuan K; Yanlin W
Braz J Med Biol Res; 2012 Jul; 45(7):676-80. PubMed ID: 22584638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
